All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
10 warning events since 2017; the latest 2026-09-28.
From the record
Nexalin Technology, Inc.'s filings since 2017 show 10 warning events of 2 kinds: a notice about its exchange listing (8-K item 3.01, 8 times, the latest 2026-09-28); an auditor change (8-K item 4.01, 2 times, the latest 2025-04-17) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+20.3% a year over 5 filed years; profitable in 0 of 5.
From the record
Nexalin Technology, Inc.'s 5 filed years say what it did: revenue went from $144 thousand in fiscal 2021 to $302 thousand in fiscal 2025, up 20.3% a year; it rose in 3 of 4 years; the deepest fall was 92% from fiscal 2022 to fiscal 2023; net income was positive in 0 of 5 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 3.5/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Nexalin Technology, Inc.'s shareholder treatment is put at 3.5 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 35% of 27 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -219%: lost 219¢ per shareholder dollar. Leverage 19%: owes 19¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Nexalin Technology, Inc. lost about 219 cents for every dollar of shareholders' money, and gross profitability: its products earned about 5 cents per dollar of everything the company owns. Leverage: it owed about 19 cents per dollar of assets, and net share issuance: its share count grew 77.9% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 5% of 24 in its family; net margin -2725.8%.
From the record
Nexalin Technology, Inc.'s standing among 24 graded names in its industry family: revenue of $302 thousand in fiscal 2025 ranks in the bottom 6% by size; a net margin of -2725.8% ranks in the bottom 6%; revenue growth of -38.9% a year over the last 3 filed years ranks in the bottom 2% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 3.4/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Nexalin Technology, Inc.'s leadership is put at 3.4 of 10 with a confidence of 35 of 100, because read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the bottom 34% of 25 in its family; the record of its people begins on 2022-09-15 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 4.2 years and cannot see past it; a floor under five years is not read as years in charge. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
top 44% of 23 in its family for room to expand.
From the record
Nexalin Technology, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $655 thousand against no long-term debt tagged leaves 14.1% of its assets as net cash, bottom 40% of its family; cash from operations less capital spending is -1643.5% of revenue (bottom 2%); a gross margin of 79.7% (top 15%); research spending of 359.2% of revenue (top 2%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
top 41% of 25 in its family for growth drivers.
From the record
Nexalin Technology, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -38.9% a year over the last three filed years against 20.3% over all 5, slowing (bottom 11% of its family); the newest year grew 78.9% (top 7%); research spending grew 28.5% a year (top 26%) (its annual reports). Nexalin Technology, Inc. reported 4 product lines in fiscal 2025: Device Sales at $136 thousand (45%), Equipment at $89 thousand (30%), Licensing Fee at $49 thousand (16%), and 1 more; 3 of 4 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
top 31% of 20 in its family for expectations against reality.
From the record
Nexalin Technology, Inc.'s newest year against its own record: revenue of $302 thousand in fiscal 2025 came in 400% above the $60 thousand its prior three years' pace pointed to (top 2% of its family); net income of $8 million against a prior three-year average of $5 million (bottom 11%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 2%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made